Publications

MPS Authors Authors in order Year Title Journal
Anne Whitehead, John Whitehead, Kim Bolland, Sue Todd Whitehead, J., Whitehead, A., Todd, S., Bolland, K., Sooriyarachchi, M. R. 2001 Mid-trial reviews for sequential clinical trials Statistics in Medicine 20, 165-176
Anne Whitehead, John Whitehead, Nigel Stallard, Sue Todd Todd, S., Whitehead, A., Stallard, N., Whitehead, J. 2001 Interim analyses and sequential designs in phase III studies British Journal of Clinical Pharmacology 51, 394-399
John Whitehead Whitehead, J. 2001 Monotherapy trials: sequential design Epilepsy Research 45, 81-87
Anne Whitehead, John Whitehead, Nigel Stallard, Sue Todd, Yinghui Zhou Whitehead, J., Zhou, Y., Stallard, N., Todd, S., Whitehead, A. 2001 Learning from previous responses in phase I dose-escalation studies British Journal of Clinical Pharmacology 52, 1-7
John Whitehead, Yinghui Zhou Whitehead, J., Zhou, Y., Patterson, S., Webber, D., Francis, S. 2001 Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers Biostatistics 2, 47-61
Anne Whitehead Whitehead, A., Omar, R. Z., Higgins, J. P. T., Savaluny, E., Turner, R. M., Thompson, S. G. 2001 Meta-analysis of ordinal outcomes using individual patient data Statistics in Medicine 20, 2243-2260
John Whitehead Whitehead, J. 2001 Predicting the duration of sequential survival studies Drug Information Journal 35, 1387-1400
Anne Whitehead, John Whitehead, Nigel Stallard, Sue Todd Stallard, N., Whitehead, J., Todd, S., Whitehead, A. 2001 Stopping rules for phase II studies British Journal of Clinical Pharmacology 51, 523-529
Anne Whitehead Higgins, J. P. T., Whitehead, A., Turner, R. M., Omar, R. Z., Thompson, S. G. 2001 Meta-analysis of continuous outcome data from individual patients Statistics in Medicine 20, 2219-2241
John Whitehead, Sue Todd Whitehead, J., Todd, S., Hall, W. J. 2000 Confidence intervals for secondary parameters following a sequential test Journal of the Royal Statistical Society, Series B 62, 731-745
Anne Whitehead Boden, W. E., Van Gilst, W. H., Scheldewaert, R., Starkey, I. R., Carlier, M. F., Julian, D. G., Whitehead, A., Betrand, M. E., Col, J. J., Lederballe Pedersen, O., Lie, K. I., Santoni, J. P., Fox, K. M. 2000 Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial The Lancet 355, 1751-1756
John Whitehead Whitehead, J. 2000 Monitoring and evaluating clinical trials data Intensive Care Medicine 26, S84-S88
John Whitehead, Kim Bolland Bolland, K., Whitehead, J. 2000 Formal approaches to safety monitoring of clinical trials in life-threatening conditions Statistics in Medicine 19, 2899-2917
Anne Whitehead, Nigel Stallard Stallard, N., Whitehead, A. 2000 Modified Weibull multi-state models for the analysis of animal carcinogenicity data Environmental and Ecological Statistics 7, 117-133
Anne Whitehead Holgate, S. T., Crockett, A. W. B., Gelder, C., Harrison, T., Hill, L. S., Neville, R. G., Rees, P. J., Whitehead, A. 2000 Managing symptomatic, adult and adolescent asthma patients: new insights from evidence-based medicine Pulse Supplement, United Business Media Ltd: London.
John Whitehead Lees, K., Asplund, K., Carolei, A., Davies, S. M., Diener, H-C., Kaste, M., Orgogozo, J-M., Whitehead, J. 2000 Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial Lancet 355, 1949-1954
John Whitehead Patterson, S., Francis, S., Ireson, M., Webber, D., Whitehead, J. 1999 A novel Bayesian decision procedure for early-phase dose-finding studies Journal of Biopharmaceutical Statistics 9, 583-597
John Whitehead Whitehead, J. 1999 On being the statistician on a data and safety monitoring board Statistics in Medicine 18, 3425-3434.
Anne Whitehead Whitehead, A., Bailey, A., Elbourne, D. 1999 Combining summaries of binary outcomes with those of continuous outcomes in a meta-analysis Journal of Biopharmaceutical Statistics 9, 1-16
John Whitehead, Nigel Stallard Stallard, N., Thall, P. F., Whitehead, J. 1999 Decision-theoretic designs for phase II clinical trials with multiple outcomes Biometrics 55, 971-977

Pages